Connection
Jennifer Goldman to Biomarkers
This is a "connection" page, showing publications Jennifer Goldman has written about Biomarkers.
|
|
Connection Strength |
|
 |
|
 |
|
0.435 |
|
|
|
-
Goldman J, Becker ML, Jones B, Clements M, Leeder JS. Development of biomarkers to optimize pediatric patient management: what makes children different? Biomark Med. 2011 Dec; 5(6):781-94.
Score: 0.383
-
van Haandel L, Goldman JL, Pearce RE, Leeder JS. Urinary biomarkers of trimethoprim bioactivation in vivo following therapeutic dosing in children. Chem Res Toxicol. 2014 Feb 17; 27(2):211-8.
Score: 0.028
-
Bass JA, Goldman J, Jackson MA, Gasior AC, Sharp SW, Drews AA, Saunders CJ, St Peter SD. Pediatric Crohn disease presenting as appendicitis: differentiating features from typical appendicitis. Eur J Pediatr Surg. 2012 Aug; 22(4):274-8.
Score: 0.025